Numerous inositol phosphates occur ubiquitously in biological tissues. The most extensively characterized, inositol 1,4,5-trisphosphate (InsP 3 ), 1 releases calcium from intracellular stores (1) . Recently the function of some of the inositol tetrakispospate isomers has been elucidated. Inositol 1,4,5,6-tetrakisphosphate may modulate the InsP 3 generated calcium signaling (2-4), whereas inositol 3,4,5,6-tetrakisphosphate is a physiologic inhibitor of calcium-activated chloride channels (5, 6) . Functions of other inositol phosphates have not been fully characterized (7) . Recently, a group of higher inositol phosphates containing energetic pyrophosphate bonds and including disphosphoinositol pentakisphosphate (PP-InsP 5 /InsP 7 ) and bis(diphospho)inositoltetrakisphosphate (bis-PP-InsP 4 / InsP 8 ) has been identified (8) . Additional inositol pyrophosphates have been described in which one of the hydroxyl groups of inositol is not phosphorylated as exemplified by disphosphoinositol tetrakisphosphate (PP-InsP 4 ) (9) . It has been suggested that the high energy pyrophosphates participate in protein phosphorylation, whereas the high turnover rate of inositol pyrophosphates (10) could represent molecular switching activity.
The high affinity binding of inositol hexakiphosphate (InsP 6 ) and InsP 7 to a variety of clathrin-associated proteins including AP2 (11) and AP-180 (12, 13) , as well to the yeast coatomer (14) , suggest a role in vesicular trafficking. Yeast with deletion of InsP 6 K display an unusual vacuolar morphology (15) .
Recently Morrison and colleagues (16) suggested a role for InsP 6 K2 as a mediator of growth inhibition and apoptosis in response to interferon-␤. Overexpression of InsP 6 K2 in ovarian carcinoma cell lines reinforces the growth suppressive and apoptotic effects of interferon-␤ treatment (16) .
Inositol pyrophosphates can be formed by several enzymes. InsP 7 and InsP 8 are synthesized by two inositol hexaphosphate kinases (InsP 6 Ks) designated InsP 6 K1 (17) and InsP 6 K2 (17) . A protein with InsP 7 kinase activity was purified but not cloned (18) . PP-InsP 4 is synthesized by InsP 6 K1 and InsP 6 K2 using InsP 5 as substrate (15) , as well by inositol phosphate multikinase (IPMK) an enzyme cloned from mammalian sources (19) and yeast (17) .
Based on our identification of three distinct protein bands interacting with an antibody to InsP 6 K, we explored data bases and uncovered a sequence that might represent a third InsP 6 K. We now describe the molecular cloning and characterization of human InsP 6 K3 (hInsP 6 K3), a new member of the InsP 6 kinases family with high densities in the brain and localizations in the nucleus and cytoplasm. (15) . All the radiolabeled inositol phosphates synthesized were purified by HPLC and desalted (9) .
EXPERIMENTAL PROCEDURES

Materials
Generation of InsP 6 K-specific Antibody-In collaboration with Affinity BioReagents, Inc. (Golden, CO), immune serum was raised against the synthetic peptide PCVLDLKMGTROHGDDAS localized in the conserved catalytic domain of InsP 6 Ks (see Figs. 1 and 3) . Affinity purification of the serum was subsequently performed using the antigenic peptide.
Identification, Cloning, and Expression of Human InsP 6 K3-We used the amino acid sequence of mInsP 6 K1 and hInsP 6 K2 to screen the human genome data bank using the TBLAST program (20) . We were able to localize InsP 6 K1 and InsP 6 K2 genes on chromosome 3 and to identify on chromosome 6 a new gene with substantial similarity to the InsP 6 Ks (see "Results"). We used the sequence information to synthesize the following gene-specific oligonucleotide primers: GSP1 (5Ј-GGT-GGCTTCCATTATGTAGGAACTGATAG-3Ј) and GSP2 (5Ј-GTGTCA-CAGTACACGCATCCCTGTGTCC-3Ј). We used these primers to perform 5Ј and 3Ј rapid amplification of cDNA ends using a human brain Marathon-Ready TM cDNA kit (CLONTECH, Palo Alto, CA), fol- lowing the manufacturer's instructions. The hInsP 6 K3 cDNA was amplified from the 5Ј-and 3Ј-rapid amplification of cDNA ends products using the supplied AP1 oligo and cloned in NotI site of Bluescript SKϩ. The plasmid was sequenced on both strands using a PerkinElmer Abi Prism 310 genetic analyzer (Foster City, CA). The ORF for human InsP 6 K3 was polymerase chain reaction-amplified using the following primers: 5Ј-GCGTCGACCATGGTTGTGCAAAACAGCGC-3Ј and 5Ј-GCGTCGACTCATTCTCCCTCTTGGATATCC-3Ј, and subcloned in the SalI site of the prokaryotic expression vector pGEX 4T-2 (Amersham Pharmacia Biotech). The ORF hInsP 6 K3 was also polymerase chain reaction-amplified using the following oligos 5Ј-GCACTCGAGTCATG-GTTGTGCAAAACAGCGC-3Ј and 5-GCAGAATTCTCATTCTCCCTCT-TGGAT-3Ј and subcloned in the XloI and EcoRI sites of the pTrcHis expression vector (Invitrogen, Carlsbad, CA). We used His-hInsP 6 K3 to mutagenize lysine 217 to alanine and serine 335 to alanine using the following oligo: K217A, 5Ј-CCCTGTGTCCTGGATCTGGCCATGGG-GACCCGGCAGCAC-3Ј and complement; S335A, 5Ј-CATACCGCTTC-TATTCCAGCGCTCTCCTTGTCATCTATG-3Ј and complement. Transformation of Escherichia coli (strain BL21), induction with isopropyl-1-thio-D-galactopyranoside and isolation of glutathione S-transferase fusion proteins using glutathione agarose (Sigma, Saint Louis, Mo) and of poly(His)-tagged proteins using Talon resin (CLONTECH, Palo Alto, CA) were performed according to the manufacturer's recommendations.
Enzyme Assays-Recombinant hInsP 6 K3 (10 -20 ng) was incubated at 37°C in 20 l of buffer containing 20 mM HEPES, pH 7.0, 6 mM MgCl, 1 mM dithiothreitol, 10 mM ATP, 1 mM NaF, 20 mM phosphocreatine, 1 mM EDTA, 0.01 mg/ml phosphocreatine kinase (Calbiochem, San Diego, CA). About 5000 cpm of the specific 3 H-labeled inositol phosphate was added. Kinetic parameter determinations were done under initial rate conditions (Ͻ10% of product formation). The assays were quenched with ice-cold perchloric acid and neutralized before HLPC analysis as described previously (21) . Briefly, the activity of recombinant enzymes was assessed using a 4.6 ϫ 125-mm Partisphere SAX column (Whatman Inc., Clifton, NJ). The column was eluted with a gradient generated by mixing Buffer A (1 mM Na 2 EDTA) and Buffer B (Buffer A plus 1.3 M (NH 4 ) 2 HPO 4 , pH 3.8, with H 3 PO 4 ) as follows: 0 -5 min, 0% B; 5-10 min, 0 -30% B; 10 -60 min, 30 -100% B; and 60 -75 min, 100% B. The fractions (1 ml) were collected and counted using 5 ml of Ultima-Flo AP LCS-mixture (Packard, Downers Grove, IL).
Northern Blot Analysis-Total RNA was isolated from various mouse organs using LiCl precipitation methods (22) . RNA (20 -40 g) was loaded on 1% agarose/formaldehyde/MOPS gel and transferred to Hybond TM N ϩ nylon membrane (Amersham Pharmacia Biotech). ORFs for hInsP 6 K3 were labeled with [␣-32 P]dCTP using oligo labeling as described (22) . Hybridization and washing was carried out following the manufacturer's instructions.
In Situ Hybridization-Freshly frozen mouse brain sections (2-3 months old, C57/Black6 male) were fixed with 4% paraformaldehyde/ PBS, permeabilized, and hybridized in 50% formamide, 5% SSC with 100 ng/ml of unhydrolyzed digoxygenin-labeled probe overnight at 55°C. The sections then were washed, blocked, and incubated overnight at 4°C in 4% normal goat serum in TBS with antidigoxygenin-AP antibody (Roche Molecular Biochemicals) at 1:5000 dilution. After washing in TBS, the slides were developed with 1 ml of color development solution containing 3.375 mg/ml nitroblue tetrazolium, 3.5 mg/ml 5-bromo-4-chloro-3-indolylphosphate, and 0.24 mg/ml levamisole, in the dark. The color reaction was allowed to run for 48 h at room temperature. The reaction was stopped in double distilled H 2 O, and the slides were sealed in Aquapolymount. Unique probes for hInsP 6 K3 were generated from cDNA corresponding to the ORF of hInsP 6 K3 subcloned in the SalI site of Bluescript SKϩ plasmid (Stratagene, La Jolla, CA). The templates were generated by T7 and T3 RNA polymerases. The sense control probes used at equal concentrations generated no specific signal.
Subcellular Localization of mInsP 6 K1, hInsP 6 K2, and hInsP 6 K3-The ORF of InsP 6 K1, InsP 6 K2, and InsP 6 K3 were subcloned in the sites XhoI and EcoRI of enhanced green fluorescent protein pEGFP-C1 plasmid (CLONTECH, Palo Alto, CA). GFP-mInsP 6 K1, GFP-hInsP 6 K2, and GFP-hInsP 6 K3 plasmids were transient transfected into 70% confluent HEK 293 cells using LipofectAMINE 2000 (Life Technologies, INc.). The cells were grown in 5% CO 2 at 37°C and maintained in Dulbecco's modified Eagle's medium (Life Technologies, Inc.) supplemented with 1% (w/v) glutamine, 1% penicillin/streptomycin, and 10% (v/v) fetal-calf serum. After 24 h, transiently transfected cells were fixed for 30 min with 4% formaldehyde in PBS and washed three times in PBS. The nuclei were stained with 100 ng/ml 4Ј,6-diamidino-2-phenylindole for Right panel, preabsorption of the antibody with 1 mg/ml of the antigenic peptide. D, Western blot analysis using a long run of a Tris-glycine SDS-polyacrylamide gel reveals two distinct bands. Western blot analysis using a long run of a Bis-Tris NuPage gel discriminates three bands in rat brain (E) as well in rat primary of cortical neuron (F). These experiment were replicated two times.
10 min. Images of fluorescent cells were obtained on a Zeiss 510 confocal microscope.
RESULTS
Identification and Molecular Cloning of hInsP 6 K3-mInsP 6 K1 and hInsP 6 K2 display about 60% similarity in amino acid sequence. A sequence of 18 amino acids located in the catalytic domain of the enzymes is identical to mInsP 6 K1 and hInsP 6 K2. In Western blot analysis of rat brain, an antibody raised against this conserved domain (Fig. 1A) reveals a major broad band at about 49 kDa and a faint band at about 60 kDa (Fig. 1B) . Preimmune serum interacts with the 60-kDa band but not with the prominent 49-kDa band. Because InsP 6 K purified from rat brain migrates as a 50-kDa band (23) and the calculated molecular mass of cloned mInsP 6 K1 and hInsP 6 K2 is about 49 kDa (17), we conclude that our antibody specifically recognizes InsP 6 Ks. Western blot analysis of multiple tissues reveals the same broad and prominent band with the highest density in whole brain, cerebellum, and spleen, intermediate levels in the heart and testis, and the lowest levels in the kidney and liver. Preabsorption with the InsP 6 K peptide utilized in raising the antibody abolishes the 49-kDa band (Fig.  1C) .
SDS-polyacrylamide gel electrophoresis analysis reveals two InsP 6 Ks bands (Fig. 1D) , whereas Bis-Tris NuPage gel electrophoresis analysis focused on molecular masses in the InsP 6 K range discriminates three bands, suggesting that three discrete InsP 6 K enzyme proteins might exist (Fig. 1, E and F) .
To search for a putative third InsP 6 K, we examined a human genomic data base (www.ncbi.nlm.nih.gov/genome/), screening with the known sequences of mInsP 6 K1 and hInsP 6 K2 and located three discrete genes. mInsP 6 K1 and hInsP 6 K2 both occur on chromosome 3 at 3q11.1 and 3p21.31 regions, respectively. A novel gene is located on chromosome 6 (region 6p21), which we tentatively designated hInsP 6 K3 on the basis of its substantial sequence similarity to the other InsP 6 K genes (Fig.  3) . Chromosome 6q24.1 also contains a sequence that has substantial of homology to InsP 6 K2 but that lacks intron-exon organization and so is likely a pseudogene.
We employed 3Ј-and 5Ј-rapid amplification of cDNA ends to clone hInsP 6 K3 from a human brain cDNA library (GenBank TM accession number AF393812). The putative hInsP 6 K3 cDNA possesses 2,391 nucleotides (Fig. 2) . The cDNA sequence comprises 102 nucleotides of 5Ј-untranslated regions rich in G/C (64%) and does not contain an in frame start or stop codon. The ORF is codified by 1233 nucleotides, and the putative start codon is preceded by a 5Ј-CCGCC-3Ј region similar to the Kozak consensus sequence responsible for the translation 6 Ks DNA homology was calculated using a Blasta program (20) comparing the DNA sequences that define the open reading frames of the three proteins. Protein homology was calculated using a Blasta program (20) . The percentage of identity was calculated considering the identical amino acids between the two proteins, whereas the percentage of similarity also consider conserved amino acid substitutions. The GenBank™ accession numbers of the sequences are: mInsP 6 (Table I) . Homology is lower in the untranslated regions. The human InsP 6 K3 gene defines a protein containing 410 amino acids with a molecular weight of 46,431 and a theoretical pI of 8.28. This contrasts with mInsP 6 K1, which contains 433 amino acids, a molecular weight of 49,215 and a theoretical pI of 6.64, whereas hInsP 6 K2 possesses 426 amino acids, a molecular weight of 49,180, and a theoretical pI of 6.52. InsP 6 K3 display 51 and 45% sequence identity to InsP 6 K1 and InsP 6 K2, respectively, which possess 48% identity to each other. Thus, hInsP 6 K3 appears to be a somewhat smaller protein than mInsP 6 K1 or hInsP 6 K2 and is substantially more acidic than the other proteins. The more acidic character of InsP 6 K3 may derive from its lower content of basic amino acids. Thus, hInsP 6 K3 possesses 22 lysines in contrast to 25 and 35 lysines in mInsP 6 K1 and hInsP 6 K2, respectively. hInsP 6 K3 possesses 24 arginines, whereas mInsP 6 K1 and hInsP 6 K2 possess 32 and 25 arginines, respectively.
The sequence comprising the 18-amino acid peptide used to generate the antibody to InsP 6 K is highly conserved in the InsP 3 kinases (25), IPMK (19) , and mInsP 6 K1 and hInsP 6 K2 (17) and is identical in the three InsP 6 Ks (amino acids 210 -228 in hInsP 6 K3) (Fig. 3) . This sequence comprises a crucial part of the catalytic site including a lysine that binds inositol phosphates that presumably account for its conservation (26) . Splicing sites in InsP 6 K1, InsP 6 K2, and InsP 6 K3 are virtually identical (Fig. 3) , indicating that the genomic structures of the three genes are essentially the same.
hInsP 6 K3 Catalytic Activity-To assess the catalytic activity of this new member of the InsP 6 kinase family, we expressed a glutathione S-transferase-hInsP 6 K3 construct in E. coli (Fig.  4A) . The purified protein runs as a single band with a molecular weight corresponding to the sum of glutathione S-transferase and InsP 6 K3.
Incubation (29) . *, identical amino acid; ⅐, conservative amino acid change; ϩ, amino acids that define the aldo-keto reductase motif 3 (this region partially overlaps with the region SSLL); V, putative splicing sites deduced from alignment of the cDNA and genomic sequences. Because the draft of the genomic sequence lacks the first part of the protein, the first splicing site for InsP 6 K1 cannot be identified. The 18-amino acid peptide used to develop InsP 6 K-specific antibody is underlined. The GenBank TM accession number for human InsP 6 K3 is AF393812.
HPLC analysis and the appearance of a major peak corresponding to authentic InsP 7 (Fig. 4B) (Fig. 4C) . We also observe a third, smaller peak that elutes identically to a peak obtained when we incubate [ 3 H]InsP 5 with mInsP 6 K1 or hInsP 6 K2. We have previously identified this peak as bisdiphosphoinositol trisphosphate (15) . Thus, hInsP 6 K3, like mInsP 6 K1 and hInsP 6 K2, can add two pyrophosphate groups to InsP 5 . We fail to detect metabolic activity when enzyme prep- To investigate portions of hInsP 6 K3 that may be critical for catalytic activity we performed selected mutations. Previous studies have identified a lysine in InsP 3 KA that is critical for catalytic activity, presumably because it participates in binding the inositol phosphate substrate (26) . In hInsP 6 K3 this lysine occurs at position 217. Converting this lysine to an alanine abolishes enzymatic activity (Fig. 5) .
Although mInsP 6 K1, hInsP 6 K2, hInsP 6 K3, and IPMK are part of the same large family of inositol phosphate kinases, the sequences of IPMK and the InsP 6 Ks are markedly divergent. One area of amino acid identity comprises an SSLL sequence (19) , which, in hInsP 6 K3 occurs at amino acids 334 -337 (Fig.  3) . Mutation of serine 335 to alanine virtually eliminates enzyme activity (Fig. 5) .
Localization of hInsP 6 K3-Northern blot analysis reveals two prominent bands at 6 and 2 kilobases, respectively, with two fainter bands at lower molecular weight (Fig. 6A) . These four bands are present in all tissues examined but at varying densities. The tissue with highest density of any bands is the cerebellum, in which the two largest bands are especially abundant. Moderate levels are evident in the kidney, whereas other tissues have lower levels. The presence of multiple putative mRNA species implies the existence of alternative splicing.
In situ hybridization in mouse brain reveals discrete localizations for hInsP 6 K3 mRNA (Fig. 6B) . In cerebellum the highest densities occur in Purkinje cells with somewhat lower levels in granule cells. In hippocampus substantial densities occur in CA1-CA4 layers of the hippocampus as well as in the dentate gyrus. No hybridization is evident with a sense probe.
To evaluate the disposition of hInsP 6 K3 protein, we conducted Western blot analysis of a virtually pure neuronal culture of embryonic (E18) rat cerebral cortex (Fig. 1E) . We observe all three bands, indicating that the three enzymes are all expressed in neurons. However, we cannot rule out their expression in glia as well.
To examine the intracellular localizations of hInsP 6 K3 protein, we transiently transfected HEK293 cells with GFP fusion constructs of hInsP 6 K3, mInsP 6 K1, and hInsP 6 K2 and examined localizations by confocal microscopy (Fig. 7) . We observe notable differences in the localizations of the three enzymes. The disposition of mInsP 6 K1 is similar to that of GFP itself with comparable amounts of staining in the nucleus and cytoplasm. By contrast, hInsP 6 K2 appears to be almost exclusively nuclear. hInsP 6 K3, on the other hand, appears to predominate in the cytoplasm with only modest nuclear levels.
DISCUSSION
In the present study we have cloned and characterized hInsP 6 K3, a new member of the InsP 6 K family. hInsP 6 K3 was identified by screening human genome data base. We found no (15) .
In situ hybridization studies indicated a selective localization of hInsP 6 K3 to discrete neuronal populations in the brain with notably high densities in the Purkinje cells of the cerebellum and pyramidal cells of the hippocampus and dentate gyrus. We have observed virtually identical localizations for mInsP 6 K1 (27) and hInsP 6 K2. 2 The in situ hybridization studies indicate that these enzymes occur in all Purkinje cells of the cerebellum and all pyramidal cells of the hippocampus and dentate gyrus. Thus, it would appear that individual cells contain all three enzymes. Might the three enzymes manifest different functions in the same cells? Their differing intracellular localizations are consistent with this possibility. Thus, hInsP 6 K2 is almost exclusively nuclear, and mInsP 6 K1 occurs at similar densities in the nucleus and cytoplasm, whereas hInsP 6 K3 is predominantly cytoplasmic.
The principal functions suggested for the inositol pyrophosphates involve nuclear events as well as the disposition of vesicular structures in the cytoplasm. A prominent nuclear role for inositol pyrophosphates is implied by our observations that these substances mediate stimulated homologous recombination. 3 West and co-workers (28) identified InsP 6 as an important factor of end-joining DNA repair in mammalian nuclei mediated by DNA-dependent protein kinase (28) . These authors suggested that InsP 7 and InsP 8 might be the physiologic mediators of this action. Apoptosis, which involves nuclear events, appears to be influenced by InsP 6 K2 (16). Thus, deletion of InsP 6 K2 diminishes interferon-␤ induced apoptosis in tumor cells in culture, whereas cells overexpressing InsP 6 K2 are more susceptible to interferon-␤-induced cell death (16) .
InsP 6 Ks in the cytoplasm might be involved in the regulation of vesicular dynamics ascribed to inositol pyrophosphates. InsP 6 (11) and InsP 7 (13) bind with high affinity and selectivity to a variety of clathrin-associated proteins that are participants in vesicular turnover. Deletion of yeast InsP 6 K profoundly alters vesicular disposition in yeast (15) .
